"May 21, 2015 -- Urinary tract infection symptoms that don't improve with time or treatment could point to bladder cancer, a new study suggests.
That finding applies to both men and women, said lead researcher Kyle Richards, MD, from the Uni"...
No adverse events were reported in a dose-finding study conducted among patients whose bladders were instilled with twice the recommended concentration (dose) of solution of Cysview (hexaminolevulinate hydrochloride intravesical solution) .
Cysview (hexaminolevulinate hydrochloride intravesical solution) is contraindicated in patients with:
- gross hematuria
- BCG immunotherapy or intravesical chemotherapy within the past 90 days
- known hypersensitivity to hexaminolevulinate or any derivative of aminolevulinic acid
Last reviewed on RxList: 1/5/2017
Additional Cysview Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.